Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Blé FX"'
Autor:
Devaraj A; Royal Brompton Hospital, London, United Kingdom.; National Heart and Lung Institute, Imperial College London, London, United Kingdom., Ottink F; Brainomix, Oxford, United Kingdom., Rennison-Jones C; Brainomix, Oxford, United Kingdom., Blé FX; Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom., Joly O; Brainomix, Oxford, United Kingdom., Azim A; Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom.; Faculty of Medicine, University of Southampton, Southampton, United Kingdom., Gerry S; Centre for Statistics in Medicine, University of Oxford, Oxford, United Kingdom., Harston G; Brainomix, Oxford, United Kingdom.; Oxford University Hospitals National Health Service Foundation Trust, Oxford, United Kingdom; and., Ostridge K; Faculty of Medicine, University of Southampton, Southampton, United Kingdom.; Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., George PM; Royal Brompton Hospital, London, United Kingdom.; National Heart and Lung Institute, Imperial College London, London, United Kingdom.
Publikováno v:
American journal of respiratory and critical care medicine [Am J Respir Crit Care Med] 2024 May 01; Vol. 209 (9), pp. 1168-1169.
Autor:
Usmani OS; National Heart and Lung Institute, Imperial College London and Royal Brompton Hospital, London, England. Electronic address: o.usmani@imperial.ac.uk., Han MK; Division of Pulmonary and Critical Care, University of Michigan, Ann Arbor, MI., Kaminsky DA; Pulmonary and Critical Care, University of Vermont Larner College of Medicine, Burlington, VT., Hogg J; James Hogg Research Centre, University of British Columbia and St. Paul's Hospital, Vancouver, BC, Canada., Hjoberg J; formerly of AstraZeneca, Gothenburg, Sweden., Patel N; Sanofi Genzyme, Boston, MA., Hardin M; Sanofi Genzyme, Boston, MA., Keen C; Research and Early Development, Respiratory, Inflammation, and Autoimmune, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Rennard S; University of Nebraska Medical Center, Omaha, NE; Translational Science and Experimental Medicine, Respiratory, Inflammation, and Autoimmune, BioPharmaceuticals R&D, AstraZeneca, Omaha, NE., Blé FX; Translational Science and Experimental Medicine, Respiratory, Inflammation, and Autoimmune, BioPharmaceuticals R&D, AstraZeneca, Omaha, NE., Brown MN; Research and Early Development, Respiratory, Inflammation, and Autoimmune, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
Publikováno v:
Chest [Chest] 2022 Apr; Vol. 161 (4), pp. e249-e250.
Autor:
Usmani OS; National Heart and Lung Institute, Imperial College London & Royal Brompton Hospital, London, UK. Electronic address: o.usmani@imperial.ac.uk., Han MK; Division of Pulmonary and Critical Care, University of Michigan, Ann Arbor, MI., Kaminsky DA; Pulmonary and Critical Care, University of Vermont Larner College of Medicine, Burlington, VT., Hogg J; James Hogg Research Centre, University of British Columbia and St. Paul's Hospital, Vancouver, BC, Canada., Hjoberg J; formerly of AstraZeneca, Gothenburg, Sweden., Patel N; Sanofi Genzyme, Boston, MA., Hardin M; Sanofi Genzyme, Boston, MA., Keen C; Research and Early Development, Respiratory, Inflammation, and Autoimmune, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Rennard S; Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE; Translational Science and Experimental Medicine, Respiratory, Inflammation, and Autoimmune, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Blé FX; Translational Science and Experimental Medicine, Respiratory, Inflammation, and Autoimmune, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Brown MN; Research and Early Development, Respiratory, Inflammation, and Autoimmune, BioPharmaceuticals R&D, AstraZeneca, Boston, MA.
Publikováno v:
Chest [Chest] 2021 Jul; Vol. 160 (1), pp. 114-134. Date of Electronic Publication: 2021 Apr 02.
Autor:
Fleming JS; Southampton NIHR Respiratory and Critical Care Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.; Department of Medical Physics, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom., Conway J; Southampton NIHR Respiratory and Critical Care Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.; Centre for Health and Life Sciences, Brunel University, London, United Kingdom., Bennett MJ; Southampton NIHR Respiratory and Critical Care Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.; Faculty of Medicine, University of Southampton, Southampton, United Kingdom., Tossici-Bolt L; Department of Medical Physics, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom., Guy M; Department of Medical Physics, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom., Blé FX; Translational Science and Experimental Medicine, Research and Early Development, Respiratory, Inflammation and Autoimmune (RIA), R&D BioPharmaceuticals, AstraZeneca R&D, Gothenburg, Sweden., McCrae C; Translational Science and Experimental Medicine, Research and Early Development, Respiratory, Inflammation and Autoimmune (RIA), R&D BioPharmaceuticals, AstraZeneca R&D, Gothenburg, Sweden., Carlsson M; Patient Safety, Chief Medical Office, R&D, AstraZeneca, Gothenburg, Sweden., Bondesson E; Active Biotech, Lund, Sweden.
Publikováno v:
Journal of aerosol medicine and pulmonary drug delivery [J Aerosol Med Pulm Drug Deliv] 2020 Dec; Vol. 33 (6), pp. 342-356. Date of Electronic Publication: 2020 Jul 08.
Autor:
Vallejo Ramirez PP; Laser Analytics Group, Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK., Zammit J; Sensor CDT 2015-2016 student cohort, University of Cambridge, Cambridge, UK., Vanderpoorten O; Laser Analytics Group, Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK.; Sensor CDT 2015-2016 student cohort, University of Cambridge, Cambridge, UK., Riche F; Sensor CDT 2015-2016 student cohort, University of Cambridge, Cambridge, UK., Blé FX; Clinical Discovery Unit, Early Clinical Development, IMED Biotech Unit, AstraZeneca, Cambridge, UK., Zhou XH; Bioscience, Respiratory, Inflammation and Autoimmunity, IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden., Spiridon B; Sensor CDT 2015-2016 student cohort, University of Cambridge, Cambridge, UK., Valentine C; Sensor CDT 2015-2016 student cohort, University of Cambridge, Cambridge, UK., Spasov SE; Sensor CDT 2015-2016 student cohort, University of Cambridge, Cambridge, UK., Oluwasanya PW; Sensor CDT 2015-2016 student cohort, University of Cambridge, Cambridge, UK., Goodfellow G; Sensor CDT 2015-2016 student cohort, University of Cambridge, Cambridge, UK., Fantham MJ; Laser Analytics Group, Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK., Siddiqui O; Sensor CDT 2015-2016 student cohort, University of Cambridge, Cambridge, UK., Alimagham F; Sensor CDT 2015-2016 student cohort, University of Cambridge, Cambridge, UK., Robbins M; Laser Analytics Group, Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK.; Sensor CDT 2015-2016 student cohort, University of Cambridge, Cambridge, UK., Stretton A; Sensor CDT 2015-2016 student cohort, University of Cambridge, Cambridge, UK., Simatos D; Sensor CDT 2015-2016 student cohort, University of Cambridge, Cambridge, UK., Hadeler O; Laser Analytics Group, Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK., Rees EJ; Laser Analytics Group, Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK., Ströhl F; Laser Analytics Group, Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK.; Department of Physics and Technology, UiT The Arctic University of Norway, NO-9037, Tromsø, Norway., Laine RF; Laser Analytics Group, Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK.; Medical Research Council Laboratory for Molecular Cell Biology (LMCB), University College London, Gower Street, London, WC1E 6BT, UK., Kaminski CF; Laser Analytics Group, Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK. cfk23@cam.ac.uk.
Publikováno v:
Scientific reports [Sci Rep] 2019 Oct 30; Vol. 9 (1), pp. 15693. Date of Electronic Publication: 2019 Oct 30.
Autor:
Fleming JS; 1National Institute of Health Research Biomedical Research Unit in Respiratory Disease, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.; 2Department of Medical Physics, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom., Conway J; 1National Institute of Health Research Biomedical Research Unit in Respiratory Disease, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.; 3Faculty of Health Sciences, University of Southampton, Southampton, United Kingdom., Bennett MJ; 1National Institute of Health Research Biomedical Research Unit in Respiratory Disease, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom., Tossici-Bolt L; 2Department of Medical Physics, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom., Guy M; 2Department of Medical Physics, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom., Blé FX; 4Precision Medicine and Genomics, Innovative Medicines and Early Development, AstraZeneca, Royston, United Kingdom., McCrae C; 5Respiratory Inflammation and Autoimmunity (RIA) Innovative Medicines and Early Development Unit, AstraZeneca Gothenburg, Mölndal, Sweden., Carlsson M; 6Global Medicines Development, AstraZeneca Gothenburg, Mölndal, Sweden., Bondesson E; 7Clinical Studies Sweden, Forum South, Skane University Hospital, Lund, Sweden.
Publikováno v:
Journal of aerosol medicine and pulmonary drug delivery [J Aerosol Med Pulm Drug Deliv] 2019 Aug; Vol. 32 (4), pp. 175-188. Date of Electronic Publication: 2019 Mar 08.
Autor:
Georgiou L, Penny J; Manchester Pharmacy School, University of Manchester, Manchester., Nicholls G; Drug Safety and Metabolism, and., Woodhouse N; Precision Medicine and Genomics, IMED Biotech Unit, AstraZeneca, Cambridge, United Kingdom., Blé FX; Precision Medicine and Genomics, IMED Biotech Unit, AstraZeneca, Cambridge, United Kingdom., Naish JH, Hubbard Cristinacce PL
Publikováno v:
Investigative radiology [Invest Radiol] 2018 Sep; Vol. 53 (9), pp. 563-570.
Autor:
Georgiou L; From the *Centre for Imaging Sciences, and †Manchester Pharmacy School, University of Manchester, Manchester; ‡AstraZeneca Research and Development-DMPK Innovative Medicines, and §AstraZeneca Personalised Healthcare and Biomarkers iMED, Melbourn, Royston, United Kingdom., Penny J, Nicholls G, Woodhouse N, Blé FX, Hubbard Cristinacce PL, Naish JH
Publikováno v:
Investigative radiology [Invest Radiol] 2017 Feb; Vol. 52 (2), pp. 111-119.
Autor:
Maynard J; Personalised Healthcare and Biomarkers, AstraZeneca, Alderley Park, SK10 4TG, UK. Juliana.maynard@alderleyimaging.com., Emmas SA; Personalised Healthcare and Biomarkers, AstraZeneca, Alderley Park, SK10 4TG, UK., Blé FX; Personalised Healthcare and Biomarkers, AstraZeneca, Alderley Park, SK10 4TG, UK., Barjat H; Personalised Healthcare and Biomarkers, AstraZeneca, Alderley Park, SK10 4TG, UK., Lawrie E; Drug Safety and Metabolism IMED, AstraZeneca, Alderley Park, SK10 4TG, UK., Hancox U; Oncology IMED, AstraZeneca, Alderley Park, SK10 4TG, UK., Oakes D; Oncology IMED, AstraZeneca, Alderley Park, SK10 4TG, UK., Polanska UM; Oncology IMED, AstraZeneca, Alderley Park, SK10 4TG, UK., Barry ST; Oncology IMED, AstraZeneca, Alderley Park, SK10 4TG, UK.
Publikováno v:
EJNMMI research [EJNMMI Res] 2016 Dec; Vol. 6 (1), pp. 62. Date of Electronic Publication: 2016 Aug 11.
Autor:
Doblas S; Laboratory of imaging biomarkers, UMR 1149 - CRI, Inserm, Paris Diderot University, Paris, France., Almeida GS; Division of Radiotherapy and Imaging, Institute of Cancer Research, London, UK., Blé FX; Personalised Healthcare & Biomarkers, AstraZeneca, Macclesfield, UK., Garteiser P; Laboratory of imaging biomarkers, UMR 1149 - CRI, Inserm, Paris Diderot University, Paris, France., Hoff BA; Department of Radiology, University of Michigan, Ann Arbor, Michigan, USA., McIntyre DJ; CRUK Cambridge Institute, University of Cambridge, Cambridge, UK., Wachsmuth L; Department of Clinical Radiology, Münster University Hospital, Westfälische Wilhelms-Universität, Münster, Germany., Chenevert TL; Department of Radiology, University of Michigan, Ann Arbor, Michigan, USA., Faber C; Department of Clinical Radiology, Münster University Hospital, Westfälische Wilhelms-Universität, Münster, Germany., Griffiths JR; CRUK Cambridge Institute, University of Cambridge, Cambridge, UK., Jacobs AH; European Institute for Molecular Imaging, Westfälische Wilhelms-Universität, Münster, Germany., Morris DM; Centre for Imaging Sciences, University of Manchester, Manchester, UK., O'Connor JP; Institute of Cancer Sciences, University of Manchester, Manchester, UK., Robinson SP; Division of Radiotherapy and Imaging, Institute of Cancer Research, London, UK., Van Beers BE; Laboratory of imaging biomarkers, UMR 1149 - CRI, Inserm, Paris Diderot University, Paris, France., Waterton JC; Centre for Imaging Sciences, University of Manchester, Manchester, UK.
Publikováno v:
Journal of magnetic resonance imaging : JMRI [J Magn Reson Imaging] 2015 Dec; Vol. 42 (6), pp. 1759-64. Date of Electronic Publication: 2015 May 26.